These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 31249236
1. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome. Arumugam V, Bhowmick R, Agarwal I, Arumadi M. Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236 [Abstract] [Full Text] [Related]
2. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes. Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M. J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809 [Abstract] [Full Text] [Related]
3. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies. Phillips EH, Westwood JP, Brocklebank V, Wong EK, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship TH, Kavanagh D, Scully MA. J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391 [Abstract] [Full Text] [Related]
4. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S. Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620 [Abstract] [Full Text] [Related]
7. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A, French Reference Center for Thrombotic Microangiopathies. Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178 [Abstract] [Full Text] [Related]
8. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy. Che M, Moran SM, Smith RJ, Ren KYM, Smith GN, Shamseddin MK, Avila-Casado C, Garland JS. Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703 [Abstract] [Full Text] [Related]
9. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity. Rossio R, Lotta LA, Pontiggia S, Borsa NG, Garagiola I, Ardissino G, Mikovic D, Cugno M, Peyvandi F. Haematologica; 2015 Mar; 100(3):e87-9. PubMed ID: 25381125 [No Abstract] [Full Text] [Related]
15. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD. Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550 [Abstract] [Full Text] [Related]
16. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab. Pecoraro C, Ferretti AV, Rurali E, Galbusera M, Noris M, Remuzzi G. Am J Kidney Dis; 2015 Dec; 66(6):1067-70. PubMed ID: 26409664 [Abstract] [Full Text] [Related]